Anzeige
Mehr »
Login
Samstag, 11.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
306 Leser
Artikel bewerten:
(1)

Hardman & Co Research: Chesnara plc (CSN): Market benefits overwhelm operational challenges

DJ Hardman & Co Research: Chesnara plc (CSN): Market benefits overwhelm operational challenges

Hardman & Co Research Hardman & Co Research: Chesnara plc (CSN): Market benefits overwhelm operational challenges 24-May-2022 / 07:00 GMT/BST

-----------------------------------------------------------------------------------------------------------------------

Hardman & Co Research: Market benefits overwhelm operational challenges Chesnara has announced its 2021 full-year results. The headline figures are good, with Economic Value earnings of GBP57.8m. Within this, there were strong positive results from economic variances. Operational variances showed the effect of the challenges to the Swedish business, in particular, although their negative contribution of GBP32.6m was a distinct improvement on the GBP49.9m loss in 2020. The final dividend increased by 3% to give a total for the year of 22.60p. On the balance sheet, the growth in Economic Value was offset by adverse movements in exchange rates; net, it shrank by 2%.

Please click on the link below for the full report:

https://hardmanandco.com/research/corporate-research/market-benefits-overwhelm-operational-challenges/

If you are interested in meeting the company, you can register your interest by clicking on the above link

To contact us: 
Hardman & Co            Contact: 
1 Frederick's Place 
                  Dr Brian Moretta 
London                        mb@hardmanandco.com 
EC2R 8AE 
                  +44(0)20 3693 7075 
www.hardmanandco.com 
Follow us on Twitter @HardmanandCo 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

-----------------------------------------------------------------------------------------------------------------------

Dissemination of a CORPORATE NEWS, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

End of Announcement - EQS News Service

1359353 24-May-2022

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1359353&application_name=news

(END) Dow Jones Newswires

May 24, 2022 02:00 ET (06:00 GMT)

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2022 Dow Jones News
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.